Adagene Inc. American Depositary Shares (ADAG)
Stock · NASDAQ · Health Care
$3.68as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$3.58
Industry
Biotechnology: Pharmaceutical Preparations
About ADAG
Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 128
- Website
- www.adagene.com/
Fundamentals
- 1-day range
- $3.66$3.87
- Market cap
- $239.77M
- P/E (trailing)
- —
- P/E (forward)
- -6.57
- EPS (trailing)
- $-0.30
- Dividend yield
- —
- Beta
- 0.54
- Avg. volume
- 269.7K
52-week range
$1.3$4.85
Forecasts
6 analyst ratings
Buy 85%
Hold 15%
Sell 0%
1-year price forecast
High
$17.45
+374.2%
Median
$9
+144.6%
Low
$7
+90.2%
Adagene Inc. American Depositary Shares Competitors
Chosen by industry and closest market cap.
- ADAGAdagene Inc. American Depositary Shares$3.68▼ 5.64%Market cap $239.77MP/E —$1.3$4.85
- MGNXMacroGenics Inc. Common Stock$4.13▲ 1.23%Market cap $242.81MP/E —$1.29$5.08
- SLGLSol-Gel Technologies Ltd. Ordinary Shares$69.41▼ 4.35%Market cap $230.38MP/E —$21$97.97
- VRXAVeraxa Biotech AG Ordinary Shares$1.36▼ 5.56%Market cap $258.78MP/E —$1.32$27.36
- ALXOALX Oncology Holdings Inc. Common Stock$2▼ 2.44%Market cap $259.71MP/E —$0.96$2.66
- ELDNEledon Pharmaceuticals Inc. Common Stock$3.19▼ 3.92%Market cap $264.75MP/E —$1.35$4.6
- WHWKWhitehawk Therapeutics Inc. Common Stock$4.65▼ 4.52%Market cap $212.98MP/E —$1.76$5.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ADAG Adagene Inc. American Depositary Shares | $239.77M | — | $3.68 | ▼ 5.64% | $1.3$4.85 |
| MGNX MacroGenics Inc. Common Stock | $242.81M | — | $4.13 | ▲ 1.23% | $1.29$5.08 |
| SLGL Sol-Gel Technologies Ltd. Ordinary Shares | $230.38M | — | $69.41 | ▼ 4.35% | $21$97.97 |
| VRXA Veraxa Biotech AG Ordinary Shares | $258.78M | — | $1.36 | ▼ 5.56% | $1.32$27.36 |
| ALXO ALX Oncology Holdings Inc. Common Stock | $259.71M | — | $2 | ▼ 2.44% | $0.96$2.66 |
| ELDN Eledon Pharmaceuticals Inc. Common Stock | $264.75M | — | $3.19 | ▼ 3.92% | $1.35$4.6 |
| WHWK Whitehawk Therapeutics Inc. Common Stock | $212.98M | — | $4.65 | ▼ 4.52% | $1.76$5.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Adagene H1 Adj. EPS $(0.20) Misses $(0.10) Estimate, Sales $1.620MBenzinga · 8/12/2026
Insider Activity
Insider Actions →Acquired
43.2K
Disposed
0
Institutional Ownership
March 31, 2026
- Total shares held
- 3.30M
- Total value held
- $9.70M
- Institutional holders
- 24
Top holders this quarter
- Unknown1.34M
- Unknown736.8K
- Unknown607.9K
- Unknown199.6K
- Unknown66.1K
- Unknown47.1K
- Unknown40.3K
- Unknown38.1K
- Unknown35.1K
- Unknown34.8K
See the full, filterable feed with live charts on the MarketWall dashboard.